20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Recommended Webinars & Conferences
Journal Flyer
Flyer image

Pratheeshkumar Poyil

Pratheeshkumar Poyil

Pratheeshkumar Poyil
Associate Scientist
King Faisal Specialist Hospital & Research Center, Saudi Arabia

Biography

Dr. Pratheeshkumar Poyil is an Associate Scientist at Human Cancer Genomics Research, King Faisal Specialist Hospital and Research Centre (KFSH&RC) Riyadh, Saudi Arabia. Before joining at KFSH&RC, he was a Research Associate in the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, USA for a period of 2011- 2016. He received his PhD degree in Tumor Immunology from Mahatma Gandhi University in 2011. He has been an author or co-author of more than 60 published research articles including reviews and book chapters; these articles have received 1543 citations with an H-index of 24 (Google Scholar, up to March 10, 2018). Add to this, he is an active reviewer of more than 20 international research journals. He is a member of editorial boards of International Journals and served as guest editor for 4 special journal issues in his research area. He is a highly motivated and innovative molecular biologist expertise in development and execution of translational biology, genetic and biochemistry-based research methods. His research interest includes the elucidation of cancer chemo-resistance mechanisms; identification of novel therapeutic targets in breast, papillary thyroid, colon and ovarian cancers and their targeting with small molecule inhibitors.

Research Interest

Cancer Biology and Translational Research, Molecular Carcinogenesis, Cell cycle regulation and apoptosis, tumor Immunology, Prevention and Therapy of cancer, Targeted Cancer Therapy with small molecular inhibitors, Molecular Mechanisms of Tumor Angiogenesis and Metastasis.